Clinical trials: sponsored by Oslo University Hospital
Chronic Pain, Widespread
Living Well with Chronic Pain
The goal of this project is to test the effect of an interactive e-health intervention for people with chronic pain.
- Trial name
- EPIO (NCT03705104)
- Testing
- EPIO
- Where
- Norway
- Volunteers
- 340 people
- Sponsor
- Oslo University Hospital
Retinitis Pigmentosa 11, Retinitis Pigmentosa
Natural History Study of Retinitis Pigmentosa Type 11
Observational study of patients with retinitis pigmentosa type 11
- Trial name
- ReSa (NCT04805658)
- Testing
- Clinical examinations
- Where
- Norway
- Volunteers
- 30 people
- Sponsor
- Oslo University Hospital
Weight, Body
ECHANGE: EHealth Design to Facilitate Weight Maintenance Following Initial Weight Loss
The aim of this study is to evaluate an eHealth intervention facilitating weight maintenance following initial weight loss during a 3-month trial (pilot test)
- Trial name
- eCHANGE (NCT04537988)
- Testing
- Behavioral: eCHANGE
- Where
- Norway
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Multiple Myeloma
REST - Replacing Steroids in the Transplant Ineligble
Newly diagnosed multiple myeloma patients ineligible for HD-ASCT will be included in the study. All participants will receive isatuximab in combination with bortezomib, lenalidomide and minimal dexamethasone until disease…
- Trial name
- REST (NCT04939844)
- Testing
- Isatuximab, bortezomib, lenalidomide, dexamethason
- Where
- 4 sites in Denmark, Norway
- Volunteers
- 51 people
- Sponsor
- Oslo University Hospital
Cancer, Stress, Psychological
Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial
The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.
- Trial name
- NCT02939612
- Testing
- App for stress management
- Where
- Norway
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Multiple Myeloma
The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
The REMNANT study will evaluate whether treating minimal residual disease (MRD) relapse after first line treatment prolongs progression free survival and overall survival for myeloma patients versus treating relapse after first…
- Trial name
- NCT04513639
- Testing
- Early treatment of relapse with carfilzomib, dexamethasone, daratumumab, Standard treatment of relapse with carfilzomib, dexamethasone, daratumumab
- Where
- 13 sites in Norway
- Volunteers
- 176 people
- Sponsor
- Oslo University Hospital
Depression
Mechanisms of Change in Psychotherapy
Background: Major depressive disorder (MDD) is a prevalent psychiatric condition associated with significant disability, mortality and economic burden.
- Trial name
- MOP (NCT03022071)
- Testing
- Cognitive behavior therapy
- Where
- Norway
- Volunteers
- 100 people
- Sponsor
- Oslo University Hospital
Systemic Sclerosis (SSc), Pulmonary Arterial Hypertension (PAH)
Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
The goal of this observational pilot trial is to evaluate the feasibility of home monitoring for patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH).
- Conditions
- Systemic Sclerosis (SSc), Pulmonary Arterial Hypertension (PAH), Home Monitoring Follow-up
- Trial name
- Nor-SScCare (NCT06865118)
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- Oslo University Hospital
Kidney Transplantation
Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled Study
A randomized controlled study (RCT) aiming to test the effect of a new health literacy intervention for renal transplant recipients, KnowMAP (knowledge management for renal transplant recipients).
- Trial name
- KnowMAP (NCT04296955)
- Testing
- Motivational interview as a new health communication intervention
- Where
- Norway
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Huntington Disease
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
The goal of this clinical trial is to learn if oral supplement of nicotinamide riboside (NR), a form of vitamin B3, slows disease progression in adults with Huntington's disease.
- Trial name
- NAD-HD (NCT06853743)
- Testing
- Nicotinamide Riboside (NR)
- Where
- Norway
- Volunteers
- 120 people
- Sponsor
- Oslo University Hospital
Legg Calve Perthes Disease
Perthes Disease in Norway
Calvé-Legg-Perthes disease (CLP) is a hip disease in children whose femoral head becomes completely or partially necrotic. The disease is most common in five-six years of age.
- Trial name
- NCT03885960
- Where
- Norway
- Volunteers
- 216 people
- Sponsor
- Oslo University Hospital
Postoperative Pain
Pediatric Postoperative Pain Management in Surgical Wards - an Intervention Study
This study will explore healthcare providers' pediatric postoperative pain management knowledge and clinical practice. The aim of this study is to explore healthcare providers' knowledge and clinical practice in pediatric…
- Trial name
- NCT03987399
- Testing
- Tailored educational intervention
- Where
- Norway
- Volunteers
- 650 people
- Sponsor
- Oslo University Hospital
Newborn Asphyxia, Hemodynamic Instability
Fetal Assessment of the Myocardium and Evaluation of the Neonate
FAME-n aims to improve perinatal care by introducing new approaches to fetal and neonatal heart assessment. Better identification of high-risk deliveries requiring intervention will reduce perinatal asphyxia-related illness and…
- Conditions
- Newborn Asphyxia, Hemodynamic Instability, Myocardium; Ischemic, Fetal Distress
- Trial name
- FAME-n (NCT06186973)
- Testing
- Monitoring with Neobeat heart rate meter, Maternal arterial blood gases, Amniotic fluid lactate
- Where
- Norway
- Volunteers
- 220 people
- Sponsor
- Oslo University Hospital
Rhabdomyolysis
Rhabdomyolysis - a Study of Patients and Laboratory Values to Guide Treatment
Rhabdomyolysis is a potentially life-threatening syndrome characterized by breakdown of skeletal muscle, and leakage of intracellular substances such as myoglobin and creatine kinase (CK) into the circulation.
- Trial name
- RhabdoGuide (NCT04118608)
- Testing
- No intervention
- Where
- Norway
- Volunteers
- 310 people
- Sponsor
- Oslo University Hospital
Transplant Recipient (Kidney)
Developing a Health Literacy Intervention for Immigrant Kidney Transplant Recipients
The goal of this complex interventions study is to improve health literacy (HL), medication adherence and patient education outcomes in immigrant kidney transplant recipients (KTRs).
- Trial name
- IMMIHEALTH (NCT06860139)
- Testing
- Health literacy intervention
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- Oslo University Hospital
Congenital Heart Disease in Children, Stress, Psychological
Personalized Mobile App for Parents of Infants With Cardiac Disease
This project implements an eHealth intervention targeted at vulnerable infants with cardiac disease and specifically study how this intervention impact their parents coping, stress levels and personal wellbeing.
- Trial name
- HOBS (NCT04315610)
- Testing
- Access to mobile phone application, Treatment as usual
- Where
- Norway
- Volunteers
- 154 people
- Sponsor
- Oslo University Hospital
No Condition is the Focus of the Study
Joy in Work, Resilience Capacity, and Patient Safety Culture Among Healthcare Professionals In-hospital
In this project, the investigators will investigate three important factors to optimize working conditions and patient safety: Joy in Work, Resilience Capacity, and Patient safety culture using both questionnaires and focus group…
- Trial name
- NCT06710730
- Where
- 2 sites in Norway
- Volunteers
- 400 people
- Sponsor
- Oslo University Hospital
Drug Usage
Cooperation for Better Treatment of Polypharmacy in the Community
The elderly population today relies heavily on medication consumption. While there are cases where using multiple medications is necessary and reasonable, it also increases the risk of inappropriate treatment and adverse drug…
- Trial name
- NCT06020391
- Testing
- Collaborative drug review
- Where
- Norway
- Volunteers
- 139 people
- Sponsor
- Oslo University Hospital
Head and Neck Cancer
Dose Painting of Head and Neck Cancer
Dose-painting may increase the chance of cure at minimised radiation-induced toxicity in volumetric-arc radiotherapy (VMAT) for head and neck cancer.
- Trial name
- RADPAINT (NCT03847480)
- Testing
- FDG-PET guided dose painting
- Where
- Norway
- Volunteers
- 7 people
- Sponsor
- Oslo University Hospital
Juvenile Idiopathic Arthritis
Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA).
Inhibitors of tumour necrosis factor (TNFa) reduce inflammation in patients with juvenile idiopathic arthritis (JIA), but only 20-40 percent achieve a state of no or very little disease activity.
- Trial name
- MyJIA (NCT04614311)
- Testing
- Triamcinolone Hexacetonide 20 MG/ML
- Where
- 5 sites in Norway
- Volunteers
- 189 people
- Sponsor
- Oslo University Hospital